Aubagio ‘slows brain atrophy in RRMS patients’
Aubagio ‘slows brain atrophy in RRMS patients’
Genzyme has announced results from magnetic resonance imaging (MRI) analysis of participants in the Phase III TEMSO clinical trial showing Aubagio was able to slow the loss of brain volume (or atrophy) versus a placebo over two years in patients with relapsing-remitting multiple sclerosis (RRMS)... Read More - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 11690 Views
-
Last post by accordingnature495
-
- 0 Replies
- 1800 Views
-
Last post by NHE
-
- 0 Replies
- 1483 Views
-
Last post by NHE
-
- 4 Replies
- 1530 Views
-
Last post by NHE
-
- 0 Replies
- 1233 Views
-
Last post by NHE
-
- 0 Replies
- 1562 Views
-
Last post by NHE
-
- 0 Replies
- 2031 Views
-
Last post by frodo
-
- 0 Replies
- 2067 Views
-
Last post by NHE
-
- 0 Replies
- 1670 Views
-
Last post by NHE